Clinical Trials Browser

Phase 2 × Tretinoin × Plasma cell × Clear all

NCT04700176 2025-02-25

A Study of Daratumumab With Pomalidomide, Dexamethasone, and All-Transretinoic Acid in Patients With Multiple Myeloma

Phase 2 Terminated

1 enrolled 14 charts

Multiple Myeloma

NCT06158412 2025-02-19

All-trans Retinoic Acid in Combination With a KPD Regimen for the Treatment of Refractory/Relapsed Multiple Myeloma

Phase 2 Recruiting

Multiple Myeloma